Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NAMS compared with AURA: revenue, margins and what each company keeps, and the suppliers and customers both name
NAMS
NewAmsterdam Pharma Co N.V.
Change
Mkt cap
Revenue
Revenue
AURA
Aura Biosciences, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NAMS
NewAmsterdam Pharma Co N.V.
vs
AURA
Aura Biosciences, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
No disclosed counterparties: NAMS, AURA.
Role chip = supplier or customer
Source: SEC EDGAR
NAMS
NewAmsterdam Pharma Co N.V.
Change
18.90
▲
+0.05%
· post 18.80
Mkt cap
$2.3B
Revenue
$19M
Q3 FY26
Revenue
$23M
FY25
AURA
Aura Biosciences, Inc.
Change
6.55
▲
+3.31%
· post 6.55
Closed
Nov 6 '26
Mkt cap
$680.3M
Revenue
—
Revenue
—
vs
Compare
Closed
Nov 6 '26
NAMS
NewAmsterdam Pharma Co N.V.
vs
AURA
Aura Biosciences, Inc.
18.90
▲
+0.05%
post 18.80
Price
6.55
▲
+3.31%
post 6.55
$2.3B
Mkt cap
$680.3M
Q3 FY26
$19M
Revenue
—
FY25
$23M
Revenue
—
Change
Change
NAMS
18.90
▲
+0.05%
vs
AURA
6.55
▲
+3.31%
Closed
Nov 6 '26